Risk of new tumors in von Hippel–Lindau patients depends on age and genotype
- 1 January 2016
- journal article
- Published by Elsevier in Genetics in Medicine
- Vol. 18 (1) , 89-97
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Identification of 3 novel VHL germ-line mutations in Danish VHL patientsBMC Medical Genetics, 2012
- Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 monthsFamilial Cancer, 2011
- von Hippel–Lindau disease: A clinical and scientific reviewEuropean Journal of Human Genetics, 2011
- Genetic analysis of von Hippel-Lindau diseaseHuman Mutation, 2010
- VHL Frameshift Mutation as Target of Nonsense‐Mediated mRNA Decay in Drosophila melanogaster and Human HEK293 Cell LineBioMed Research International, 2009
- von Hippel-Lindau Disease-Associated Hemangioblastomas Are Derived from Embryologic Multipotent CellsPLOS Medicine, 2007
- Genotype-phenotype correlations in von Hippel-Lindau diseaseHuman Mutation, 2006
- Second hit deletion size in von Hippel–Lindau diseaseAnnals of Neurology, 2005
- Genotype-phenotype correlation in von Hippel-Lindau families with renal lesionsHuman Mutation, 2004
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971